These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 28340985)

  • 1. Autoimmunity, Autoantibodies, and Autism Spectrum Disorder.
    Edmiston E; Ashwood P; Van de Water J
    Biol Psychiatry; 2017 Mar; 81(5):383-390. PubMed ID: 28340985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal autoantibody related autism: mechanisms and pathways.
    Jones KL; Van de Water J
    Mol Psychiatry; 2019 Feb; 24(2):252-265. PubMed ID: 29934547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of the Immune System in Autism Spectrum Disorder.
    Meltzer A; Van de Water J
    Neuropsychopharmacology; 2017 Jan; 42(1):284-298. PubMed ID: 27534269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal Anti-Fetal Brain IgG Autoantibodies and Autism Spectrum Disorder: Current Knowledge and its Implications for Potential Therapeutics.
    Fox-Edmiston E; Van de Water J
    CNS Drugs; 2015 Sep; 29(9):715-24. PubMed ID: 26369920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autism-specific maternal anti-fetal brain autoantibodies are associated with metabolic conditions.
    Krakowiak P; Walker CK; Tancredi D; Hertz-Picciotto I; Van de Water J
    Autism Res; 2017 Jan; 10(1):89-98. PubMed ID: 27312731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal Immune Activation and Autism Spectrum Disorder: From Rodents to Nonhuman and Human Primates.
    Careaga M; Murai T; Bauman MD
    Biol Psychiatry; 2017 Mar; 81(5):391-401. PubMed ID: 28137374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autism-specific maternal autoantibodies produce behavioral abnormalities in an endogenous antigen-driven mouse model of autism.
    Jones KL; Pride MC; Edmiston E; Yang M; Silverman JL; Crawley JN; Van de Water J
    Mol Psychiatry; 2020 Nov; 25(11):2994-3009. PubMed ID: 29955164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic Targets of Patient and Maternal Autoantibodies in Autism Spectrum Disorder.
    Mazón-Cabrera R; Vandormael P; Somers V
    Front Immunol; 2019; 10():1474. PubMed ID: 31379804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors in autism: Thinking outside the brain.
    Matelski L; Van de Water J
    J Autoimmun; 2016 Feb; 67():1-7. PubMed ID: 26725748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the antigenic epitopes of maternal autoantibodies in autism spectrum disorders.
    Edmiston E; Jones KL; Vu T; Ashwood P; Van de Water J
    Brain Behav Immun; 2018 Mar; 69():399-407. PubMed ID: 29289663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Maternal immune activation and risk of Autism Spectrum Disorder].
    Heresi Venegas C
    Rev Chil Pediatr; 2019 Oct; 90(5):555-558. PubMed ID: 31859740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal Antibody and ASD: Clinical Data and Animal Models.
    Gata-Garcia A; Diamond B
    Front Immunol; 2019; 10():1129. PubMed ID: 31191521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal Stress and Maternal Immune Dysregulation in Autism Spectrum Disorders: Potential Points for Intervention.
    Beversdorf DQ; Stevens HE; Margolis KG; Van de Water J
    Curr Pharm Des; 2019; 25(41):4331-4343. PubMed ID: 31742491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The positive association between elevated blood lead levels and brain-specific autoantibodies in autistic children from low lead-polluted areas.
    Mostafa GA; Bjørklund G; Urbina MA; Al-Ayadhi LY
    Metab Brain Dis; 2016 Oct; 31(5):1047-54. PubMed ID: 27250967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal immune activation dysregulation of the fetal brain transcriptome and relevance to the pathophysiology of autism spectrum disorder.
    Lombardo MV; Moon HM; Su J; Palmer TD; Courchesne E; Pramparo T
    Mol Psychiatry; 2018 Apr; 23(4):1001-1013. PubMed ID: 28322282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling Autism-Related Disorders in Mice with Maternal Immune Activation (MIA).
    Lammert CR; Lukens JR
    Methods Mol Biol; 2019; 1960():227-236. PubMed ID: 30798536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond infection - Maternal immune activation by environmental factors, microglial development, and relevance for autism spectrum disorders.
    Bilbo SD; Block CL; Bolton JL; Hanamsagar R; Tran PK
    Exp Neurol; 2018 Jan; 299(Pt A):241-251. PubMed ID: 28698032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and autoimmune features of a patient with autism spectrum disorder seropositive for anti-NMDA-receptor autoantibody.
    Gréa H; Scheid I; Gaman A; Rogemond V; Gillet S; Honnorat J; Bolognani F; Czech C; Bouquet C; Toledano E; Bouvard M; Delorme R; Groc L; Leboyer M
    Dialogues Clin Neurosci; 2017 Mar; 19(1):65-70. PubMed ID: 28566948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond the brain: A multi-system inflammatory subtype of autism spectrum disorder.
    Thom RP; Keary CJ; Palumbo ML; Ravichandran CT; Mullett JE; Hazen EP; Neumeyer AM; McDougle CJ
    Psychopharmacology (Berl); 2019 Oct; 236(10):3045-3061. PubMed ID: 31139876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In utero exposure to endogenous maternal polyclonal anti-Caspr2 antibody leads to behavioral abnormalities resembling autism spectrum disorder in male mice.
    Bagnall-Moreau C; Huerta PT; Comoletti D; La-Bella A; Berlin R; Zhao C; Volpe BT; Diamond B; Brimberg L
    Sci Rep; 2020 Sep; 10(1):14446. PubMed ID: 32879327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.